OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
An outlook on the trigeminovascular mechanisms of action and side effects concerns of some potential neuropeptidergic antimigraine therapies
Abimael González‐Hernández, Miguel Condés‐Lara, Enrique García-Boll, et al.
Expert Opinion on Drug Metabolism & Toxicology (2021) Vol. 17, Iss. 2, pp. 179-199
Closed Access | Times Cited: 9
Abimael González‐Hernández, Miguel Condés‐Lara, Enrique García-Boll, et al.
Expert Opinion on Drug Metabolism & Toxicology (2021) Vol. 17, Iss. 2, pp. 179-199
Closed Access | Times Cited: 9
Showing 9 citing articles:
Prolactin and oxytocin: potential targets for migraine treatment
Anna K. Szewczyk, Samiye Ulutas, Tülin Aktürk, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 22
Anna K. Szewczyk, Samiye Ulutas, Tülin Aktürk, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 22
Understanding the Biological Relationship between Migraine and Depression
Adrián Viudez‐Martínez, Abraham B. Torregrosa, Francisco Navarrete, et al.
Biomolecules (2024) Vol. 14, Iss. 2, pp. 163-163
Open Access | Times Cited: 9
Adrián Viudez‐Martínez, Abraham B. Torregrosa, Francisco Navarrete, et al.
Biomolecules (2024) Vol. 14, Iss. 2, pp. 163-163
Open Access | Times Cited: 9
Adverse event profile of CGRP monoclonal antibodies: findings from the FDA adverse event reporting database
Qi Wang, Jingfang Liu, Hao Sun, et al.
Expert Opinion on Drug Safety (2023) Vol. 23, Iss. 1, pp. 107-117
Open Access | Times Cited: 10
Qi Wang, Jingfang Liu, Hao Sun, et al.
Expert Opinion on Drug Safety (2023) Vol. 23, Iss. 1, pp. 107-117
Open Access | Times Cited: 10
Hypothalamic paraventricular stimulation inhibits nociceptive WDR trigeminocervical complex cells via oxytocinergic transmission
Miguel Condés‐Lara, Guadalupe Martínez‐Lorenzana, Antonio Espinosa de los Monteros-Zúñiga, et al.
Journal of Neuroscience (2024), pp. e1501232024-e1501232024
Open Access | Times Cited: 2
Miguel Condés‐Lara, Guadalupe Martínez‐Lorenzana, Antonio Espinosa de los Monteros-Zúñiga, et al.
Journal of Neuroscience (2024), pp. e1501232024-e1501232024
Open Access | Times Cited: 2
The influence of pharmacodynamics and pharmacokinetics on the antimigraine efficacy and safety of novel anti-CGRPergic pharmacotherapies: a narrative review
Abimael González‐Hernández, Carlos M. Villalón
Expert Opinion on Drug Metabolism & Toxicology (2024)
Closed Access | Times Cited: 2
Abimael González‐Hernández, Carlos M. Villalón
Expert Opinion on Drug Metabolism & Toxicology (2024)
Closed Access | Times Cited: 2
The impact of CGRPergic monoclonal antibodies on prophylactic antimigraine therapy and potential adverse events
Abimael González‐Hernández, Bruno A. Marichal‐Cancino, Carlos M. Villalón
Expert Opinion on Drug Metabolism & Toxicology (2021) Vol. 17, Iss. 10, pp. 1223-1235
Closed Access | Times Cited: 4
Abimael González‐Hernández, Bruno A. Marichal‐Cancino, Carlos M. Villalón
Expert Opinion on Drug Metabolism & Toxicology (2021) Vol. 17, Iss. 10, pp. 1223-1235
Closed Access | Times Cited: 4
A critical review of the neurovascular nature of migraine and the main mechanisms of action of prophylactic antimigraine medications
Bruno A. Marichal‐Cancino, Abimael González‐Hernández, Raquel Guerrero‐Alba, et al.
Expert Review of Neurotherapeutics (2021) Vol. 21, Iss. 9, pp. 1035-1050
Closed Access | Times Cited: 3
Bruno A. Marichal‐Cancino, Abimael González‐Hernández, Raquel Guerrero‐Alba, et al.
Expert Review of Neurotherapeutics (2021) Vol. 21, Iss. 9, pp. 1035-1050
Closed Access | Times Cited: 3
Novel Pharmacological Targets of Migraine: An Overview
Eduardo Rivera‐Mancilla, Antoinette MaassenVanDenBrink
Headache (2022), pp. 1-17
Closed Access | Times Cited: 2
Eduardo Rivera‐Mancilla, Antoinette MaassenVanDenBrink
Headache (2022), pp. 1-17
Closed Access | Times Cited: 2
Headache Medicine Grand Challenge: Headache: A New Frontier, A New Challenge
Frederick G. Freitag
Frontiers in Pain Research (2021) Vol. 2
Open Access | Times Cited: 1
Frederick G. Freitag
Frontiers in Pain Research (2021) Vol. 2
Open Access | Times Cited: 1
